{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:52Z","timestamp":1793946532249,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["Al-Aly-01-A-1"],"award-info":[{"award-number":["Al-Aly-01-A-1"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eclinm.2026.104183","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:08:49Z","timestamp":1789052929000},"page":"104183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of the 2025\u20132026 seasonal influenza vaccine among U.S. veterans: an observational study"],"prefix":"10.1016","volume":"100","author":[{"given":"Yan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1484-9227","authenticated-orcid":false,"given":"Taeyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-0434","authenticated-orcid":false,"given":"Ziyad","family":"Al-Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.eclinm.2026.104183_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.15585\/mmwr.mm7432a2","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - united States, 2025-26 influenza season","volume":"74","author":"Grohskopf","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eclinm.2026.104183_bib3","series-title":"Recommended Composition of Influenza Virus Vaccines for use in the 2025-2026 Northern Hemisphere Influenza Season","year":"2025"},{"issue":"8","key":"10.1016\/j.eclinm.2026.104183_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"46","key":"10.1016\/j.eclinm.2026.104183_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.46.2500854","article-title":"Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K","volume":"30","author":"Kirsebom","year":"2025","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eclinm.2026.104183_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDpha2600007","article-title":"Antibodies elicited by the 2025-2026 influenza vaccine","volume":"5","author":"Liu","year":"2026","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104183_bib7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2026.31.5.2600068","article-title":"Interim 2025\/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026","volume":"31","author":"Separovic","year":"2026","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104183_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eclinm.2026.104183_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"15","key":"10.1016\/j.eclinm.2026.104183_bib10","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of public health research - strengthening causal inference from observational data","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.eclinm.2026.104183_bib11","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104183_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/EDE.0000000000001601","article-title":"Emulating target trials to avoid immortal time bias - an application to antibiotic initiation and preterm delivery","volume":"34","author":"Caniglia","year":"2023","journal-title":"Epidemiology"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104183_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/sim.9718","article-title":"Causal inference in survival analysis using longitudinal observational data: sequential trials and marginal structural models","volume":"42","author":"Keogh","year":"2023","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104183_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104183_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41591-024-03412-w","article-title":"Mapping the effectiveness and risks of GLP-1 receptor agonists","volume":"31","author":"Xie","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2026.104183_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-086886","article-title":"Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study","volume":"392","author":"Cai","year":"2026","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104183_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJMoa2403211","article-title":"Postacute sequelae of SARS-CoV-2 infection in the Pre-Delta, Delta, and Omicron Eras","volume":"391","author":"Xie","year":"2024","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104183_bib18","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","article-title":"Association of 2024-2025 Covid-19 vaccine with Covid-19 outcomes in U.S. veterans","volume":"393","author":"Cai","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104183_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.9917","article-title":"GLP-1 receptor agonists or SGLT2 inhibitors and nonarteritic anterior ischemic optic neuropathy","volume":"9","author":"Choi","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104183_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2025-002183","article-title":"GLP-1 receptor agonists and risk of all cause and cause specific acute pancreatitis: target trial emulation","volume":"5","author":"Xie","year":"2026","journal-title":"BMJ Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104183_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2025-002150","article-title":"Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation","volume":"5","author":"Xie","year":"2026","journal-title":"BMJ Med"},{"issue":"26","key":"10.1016\/j.eclinm.2026.104183_bib22","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible \u2014 the neighborhood atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104183_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(23)00684-9","article-title":"Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study","volume":"24","author":"Xie","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"19","key":"10.1016\/j.eclinm.2026.104183_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2023.5348","article-title":"Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in fall-winter 2022-2023","volume":"329","author":"Xie","year":"2023","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.eclinm.2026.104183_bib25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.2024.7395","article-title":"Mortality in patients hospitalized for COVID-19 vs influenza in fall-winter 2023-2024","volume":"331","author":"Xie","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eclinm.2026.104183_bib26","article-title":"Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study","volume":"371","author":"Xie","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104183_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.20673","article-title":"Cases, hospitalization, and mortality in COVID-19 and influenza among veterans in 2022-2025 influenza seasons","volume":"8","author":"Xie","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104183_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MLR.0b013e31827da95a","article-title":"Predicting risk of hospitalization or death among patients receiving primary care in the veterans health administration","volume":"51","author":"Wang","year":"2013","journal-title":"Medical Care"},{"issue":"7","key":"10.1016\/j.eclinm.2026.104183_bib29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/gerona\/glab071","article-title":"Updating and validating the U.S. veterans affairs frailty index: transitioning from ICD-9 to ICD-10","volume":"76","author":"Cheng","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104183_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.eclinm.2026.104183_bib31","series-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"Harrell","year":"2001"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104183_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.15585\/mmwr.mm7509a2","article-title":"Interim estimates of 2025-26 seasonal influenza vaccine effectiveness - united States, September 2025-February 2026","volume":"75","author":"Maloney","year":"2026","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"10.1016\/j.eclinm.2026.104183_bib33","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1056\/NEJMp2407586","article-title":"\u201cTarget Trial Emulation\u201d for observational studies \u2014 potential and pitfalls","volume":"391","author":"Hubbard","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104183_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104183_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026004360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026004360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:47:30Z","timestamp":1793944050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026004360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S2589537026004360"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104183","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of the 2025\u20132026 seasonal influenza vaccine among U.S. veterans: an observational study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104183"}}